Home > News > UK rejects proven drug that treats the most common form of liver cancer because it is too expensive. Welcome to Obamacare, already in progress.

UK rejects proven drug that treats the most common form of liver cancer because it is too expensive. Welcome to Obamacare, already in progress.

September 10, 2009 Leave a comment Go to comments

docobama There you go.  Once again, nationalized health care hurts people.  Everyone who has this common liver cancer can look forward to pain and shorter lives to save the government a buck.  This is the result of nationalized health care.   Every state that has tried it, every country.  It doesn’t work.  US life expectancy increases every year.

(London, England) Proven effective against liver and kidney cancer, Bayer Company’s drug Nexavar has been rejected as too expensive by the National Institute of Health and Clinical Excellence (NICE), Britain’s healthcare bean-counting watchdog.

Nexavar received a preliminary rebuff from NICE in May but Bayer had hoped to convince the agency Nexavar was worth paying after it put forward a patient access scheme that would have reduced the cost of treatment to the National Health Service.

Bayer said the decision on its drug, known generically as sorafenib, for the treatment of hepatocellular carcinoma was a blow to patients.

"We thought we had satisfied NICE’s criteria for how Nexavar would be assessed — however, the goal posts appeared to have moved," said Nicole Farmer, the company’s British head of oncology.

"This proposal by NICE conflicts dramatically with the government’s strategy to bring UK cancer outcomes in-line with the rest of Europe, where Nexavar is already widely available in countries such as France, Germany, Spain, Italy, Romania, and Greece."

Hepatocellular carcinoma is the most common form of liver cancer, accounting for 80 to 90 percent of all primary liver tumors.

The Jawa Report: UK Rejects Cancer Drug Due to Cost

Advertisements
  1. No comments yet.
  1. No trackbacks yet.

Leave a Reply

Fill in your details below or click an icon to log in:

WordPress.com Logo

You are commenting using your WordPress.com account. Log Out / Change )

Twitter picture

You are commenting using your Twitter account. Log Out / Change )

Facebook photo

You are commenting using your Facebook account. Log Out / Change )

Google+ photo

You are commenting using your Google+ account. Log Out / Change )

Connecting to %s

%d bloggers like this: